[5] YBX1 is an RNA binding protein[6] that stabilises messenger RNAs modified with N6-methyladenosine.

[7] YBX1 is a potential drug target in cancer therapy.

[8] YB-1 helps the replication of adenovirus type 5, a commonly used vector in gene therapy.

[8] Thus, YB-1 can cause an "oncolytic" effect in YB-1 positive cancer cells treated with adenoviruses.

Y box binding protein 1 has been shown to interact with: This article incorporates text from the United States National Library of Medicine, which is in the public domain.